Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)	6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net Income/(Loss)	$ 23,652,172	$ (5,442,414)
Adjustments to reconcile Net Income/(Loss) to Net Cash used in operations:
Depreciation and amortization	8,154,748	2,364,836
Debt discount amortization		219,333
Employee stock awards	1,853,125	475,736
Stock grants	132,012	147,675
Contingent consideration payable fair value	(60,082)	(57,358)
Allowance for doubtful accounts	585,260	23,171
(Gain)/loss on disposal of assets	(12,044)	25,400
Reduction in right of use asset	268,693	205,205
Loss on Jagemann Munition Components		1,000,000
Changes in Current Assets and Liabilities
Accounts receivable	(14,210,318)	(2,349,630)
Due to (from) related parties	(277)	150
Inventories	(19,093,960)	(3,194,958)
Prepaid expenses	1,635,683	35,334
Deposits	(14,683,669)	(61,230)
Accounts payable	3,921,049	1,916,013
Accrued liabilities	1,010,222	1,145,451
Operating lease liability	(284,694)	(203,472)
Net cash used in operating activities	(7,132,080)	(3,750,758)
Cash flows from investing activities
Gemini acquisition	(50,520,840)
Purchase of equipment	(5,235,749)	(2,275,466)
Proceeds from disposal of assets	59,800
Net cash used in investing activities	(55,696,789)	(2,275,466)
Cash flow from financing activities
Payments on inventory facility	(896,287)
Proceeds from factoring liability	50,355,962	15,289,000
Payments on factoring liability	(49,066,474)	(15,220,358)
Payments on assumed debt from GDI	(50,000,000)
Proceeds from inventory facility		2,250,000
Proceeds from paycheck protection program notes		1,051,985
Proceeds from note payable related party issued		3,500,000
Payments on note payable - related party	(305,061)	(1,099,030)
Payments on insurance premium note payment	(1,074,210)	(270,233)
Payments on note payable	(4,000,000)
Common stock issued for exercised warrants	949,156	242,425
Sale of preferred stock	35,000,000
Sale of common stock		2,881,871
Issuance costs	(3,199,922)	(70,000)
Preferred stock dividends paid	(337,745)
Net cash (used in)/provided by financing activities	(22,574,581)	8,555,660
Net increase/(decrease) in cash	(85,403,450)	2,529,436
Cash, beginning of period	118,341,471	884,274
Cash, end of period	32,938,021	3,413,710
Supplemental cash flow disclosures
Interest	308,695	447,105
Income taxes
Non-cash investing and financing activities:
Acquisition stock issuances	132,645,000
Financed insurance premiums	2,166,852
Dividends accumulated on preferred stock	782,639
Operating lease liability	501,125	737,680
Note payable related party		2,635,797
Stock subscription receivable		$ 1,840,910